Subscribe to our Newsletters !!
Do you know Polymerase Chain Reaction (PCR)? PCR i
Pharmaceutical laboratories have been adopting imm
Relevant codes should be used when coding fibromya
Alembic Pharmaceuticals Limited appoints Mr. Manis
The importance of comparing the treatment of asthm
It is important to understand that natural remedie
In a world constantly in motion, Microbioz India r
Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine. Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines.
“Aurobindo is in the process of preparing a state-of-art manufacturing facility for viral vaccines that will be used to produce the COVID-19 vaccine along with other viral vaccines. The plant will comply with international standards. The company”s COVID-19 vaccine development is going according to plan,” the filing added.
Commenting on the collaboration, Aurobindo Pharma Managing Director N Govindarajan said,” It’s a matter of immense pride that BIRAC has put its trust on the vaccine capabilities. The senior leadership of Aurobindo and Auro Vaccines has extensive experience in development, manufacturing and commercialization of many vaccines.”
Department of Biotechnology Secretary and BIRAC Chairperson Renu Swarup said the partnership with Aurobindo is to serve the country”s need for a vaccine to fight this pandemic.
“The government is focussed on developing an ecosystem that nurtures and encourages new product innovation to deal with the most relevant issues to our society,” Swarup added.
Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the pharma firms in India working on the coronavirus vaccine.
